An Efficacy and Safety Study of Prucalopride in Participants With Chronic Constipation
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of prucalopride to placebo
(an inactive substance that is compared with a drug to test whether the drug has a real
effect in a clinical trial) in treatment of participants with chronic (very serious, life
threatening) constipation (decreased number of or difficulty making bowel [the intestine]
movements).
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.